Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
In August 2024, Eli Lilly & Company announced the positive outcomes of the SURMOUNT-1 trial, indicating that Tirzepatide (marketed as Zepbound and Mounjaro) decreased the risk of developing type 2 diabetes by 94% in individuals with prediabetes, obesity, or overweight
In such cases, injectable Fortified Vitamin B Complex, with a significant dose of 100 mg/mL of Vitamin B1 (thiamine), becomes a lifeline
No other approved or late-stage peptide combines all three of these pathways in a single molecule
This systemic effect may explain why users sometimes report benefits beyond the specific area being treated
US$ 21.40
US$ 28.19
US$ 28.32
US$ 20.32
US$ 26.11
US$ 22.26
